Understanding the Role of Dietary Fatty Acids on Liver Fat Metabolism in Humans
NCT01936779 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2017-01-05
Summary
High levels of fatty substances in the blood increase the risk of developing heart disease. Investigators know a lot about one of these fatty substances, cholesterol. However, there is another fatty substance in the blood called triglyceride. Investigators do not understand much about what regulates the rate at which the liver produces triglyceride and liberates it into the bloodstream after eating a meal(s). It is known that taking fish oil lowers the amount of blood triglyceride however, it remains unclear how this happens. Investigators will study if changes in liver fat metabolism, after taking fatty acids found in fish oil (n-3 fatty acids)can explain the lowering of blood triglyceride. Investigators also want to know if taking fish oil alters the amount of fat that accumulates within the liver.
Conditions
- NAFLD
Interventions
- DIETARY_SUPPLEMENT
-
Dietary supplement: fatty acid
Consumption of n-3 fatty acids for 8 weeks
- DIETARY_SUPPLEMENT
-
Dietary supplement: fatty acid
Consumption of olive oil for 8 weeks.
Sponsors & Collaborators
-
University of Oxford
lead OTHER
Principal Investigators
-
Leanne Hodson, PhD · University of Oxford
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-09-30
- Primary Completion
- 2016-04-30
- Completion
- 2016-08-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Healthy Liver - Healthy Brain
NCT05216796 ·Status: COMPLETED ·Phase: NA
-
Diet, Immunometabolism and Non-alcoholic Fatty Liver Disease
NCT05968378 ·Status: UNKNOWN ·Phase: NA
-
Molecules Associated With the Presence and Severity of Nonalcoholic Fatty Liver Disease
NCT03986684 ·Status: COMPLETED
-
Body Fat Distribution and Fat Metabolism
NCT00475774 ·Status: COMPLETED ·Phase: NA
-
Defining Circadian Metabolism in Non-alcoholic Fatty Liver Disease
NCT05962099 ·Status: UNKNOWN
-
New Non-invasive Biomarkers of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
NCT06647095 ·Status: COMPLETED
-
Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease
NCT02520609 ·Status: COMPLETED
-
Diet Impact on Hepatic Transcriptomics and Lipidomics in Pre-diabetes
NCT05965973 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Liver Health Study for Patients with NAFLD
NCT03151798 ·Status: COMPLETED ·Phase: NA
-
Palmitate Breath Test to Assess Fatty Acid Oxidation in Non Alcoholic Fatty Liver Disease (NAFLD)
NCT02363309 ·Status: COMPLETED
-
Effects of Exercise on VLDL-TG Metabolism
NCT03678727 ·Status: COMPLETED
-
Effect of Diet Composition on Liver Fat and Glucose Metabolism
NCT00930371 ·Status: COMPLETED ·Phase: NA
-
Impact of Time-restricted Feeding in NAFLD
NCT05220956 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Liver and Cardiometabolic Health Benefits on Low Carbohydrate Ketogenic Diet
NCT03141008 ·Status: COMPLETED
-
Altered Drug Disposition and Biomarkers for Diagnosis of Chronic Inflammatory Liver Disease
NCT01766960 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Fat and Carbohydrates in Obese Men
NCT01750021 ·Status: COMPLETED ·Phase: NA
-
Ernährungs-Interventions-Fettleber-Studie (Interventional Study on Nutritional Effects on NAFLD)
NCT02458586 ·Status: UNKNOWN ·Phase: NA
-
Resolution of Liver Fat in Non-alcoholic Fatty Liver Disease
NCT02558530 ·Status: COMPLETED ·Phase: NA
-
Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease
NCT05332613 ·Status: RECRUITING ·Phase: NA
-
Postprandial Lipotoxicity and Nonalcoholic Fatty Liver Disease
NCT03836443 ·Status: COMPLETED ·Phase: NA
-
The Role of Leptin Receptors in NASH
NCT00583999 ·Status: COMPLETED
-
Effect of Modified Time-restricted Feeding in Preventing Progression of Non-Alcoholic Fatty Liver Disease (NAFLD).
NCT03848390 ·Status: UNKNOWN ·Phase: NA
-
Prebiotic Fibre Supplementation and Gut Microbiota in Non-alcoholic Fatty Liver Disease
NCT02568605 ·Status: COMPLETED ·Phase: NA
-
Effect of an Low Carbon High Fat Diet on Pain- and Quality of Life in Patients With Lipedema
NCT03710798 ·Status: COMPLETED ·Phase: NA
-
Non-Alcoholic Fatty Liver Disease in a Saudi Cohort With Type 2 Diabetes Mellitus
NCT05697991 ·Status: RECRUITING